Newly-released Omics Based Clinical Trials Market analysis report by Fact.MR shows that global sales of Omics Based Clinical Trials Market in 2021 was held at US$ 26.2 Bn. With 8.1%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. Interventional Studies is expected to be the highest revenue generating segment, accounting for an absolute dollar opportunity of nearly US$ 26.6 Bn during 2022 – 2032.
The constant surge in demands for Omics-Based Clinical Trials is due to Covid-19 pandemic. The main drivers were rising investment in the pharmaceutical industry by the prominent participants to enhance their productivity, rising demand for omics-based clinical trials, and increasing prevalence of chronic disorders. Owing to this, Omics Based Clinical Trials Markets is projected to grow at a CAGR of 8.1% over the coming 10 years.
Omics-Based Clinical Trials Market was valued at US$ 26.2 Bn in 2021. Covid 19 emerged as a turning point for Omics Based Clinical Trials Market and it grew at a 7.5% annual pace compared to the previous year 2020, wherein the valuation was US$ 24.2Bn. According to Fact.MR, Omics Based Clinical Trials Market revenue is projected to increase 2.2X times between 2022 and 2032, reaching roughly US$ 61.7 Bn in 2032.
In terms of Study Design, the sub-segment Interventional Studies accounts for more than 75% of the market.
In terms of Indication, Oncology, Cardiology and Respiratory Diseases accounted for a combined share of 58.3%.
North America is the dominant region in Omics Based Clinical Trials Markets with absolute dollar opportunity of US$ 13.4 Bn during the forecast period.
North AmericaLatin AmericaEuropeAsia PacificMiddle East & Africa
Key Countries Covered
United StatesCanadaBrazilMexicoGermanyU.K.FranceSpainItalyRussiaChinaJapanSouth KoreaIndiaAustraliaSouth AfricaSaudi ArabiaUAEIsrael
Key Market Segments Covered
PhaseStudy DesignIndicationRegion
Key Companies Profiled
Parexel International CorporationPharmaceutical Product Development (PPD)Charles River LaboratoryICON plcSGS SAEli Lilly and CompanyPfizer Inc.Covance Inc.Rebus Bio
Owing to the ease of regulatory compliance, low study costs, growing patient population, and the existence of a few elite clinical institutions acting as sites, Asia-Pacific has become a hotspot for conducting clinical trials. Omics Based Clinical Trials Market revenue is estimated to expand at the fastest rate in APAC between 2022 and 2032, with a projected growth rate of around 9.0%. China’s regulatory bodies, for example, are attempting to improve the clinical trial process by shortening the total review and approval procedure.
Competitive Analysis
Due to the presence of a large number of developed as well as medium to small-sized organisations, the market for omics-based clinical trials is significantly competitive. A number of market participants are privately held or are part of the portfolios of private equity companies. Some of the key prominent players in the Omics Based Clinical Trials market include: Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer Inc., Covance Inc., Novo Nordisk, Rebus Bio.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583 E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
The On Board Units (OBU) market refers to the market for devices that are installed on vehicles to provide communication, navigation, and tracking services. OBUs are typically used in commercial transportation, including trucks, buses, and trains, as well as in fleet management and logistics operations. These devices are equipped with various technologies such as GPS, cellular, and satellite commu...
The Europe tire shredder market refers to the market for tire shredders in Europe. Tire shredders are machines that are used to shred scrap tires into smaller pieces, which can be used for a variety of applications including fuel for cement kilns, landscaping mulch...
The Europe trash compactor market refers to the market for trash compactors in Europe. A trash compactor is a machine that is used to compress waste material, reducing its volume and making it easier to transport. Trash compactors are widely used in commercial, ind...
The scrubber dryer market refers to the industry involved in the production and sale of cleaning equipment known as scrubber dryers. These machines are used for cleaning and maintaining floors in various settings such as commercial, industrial, and residential buil...
